(Q34535200)

2 August 2017

1 reference

title

The burden of invasive pneumococcal disease and the potential for reduction by immunisation (English)

1 reference

2 August 2017

Helena K Parsons

1

1 reference

2 August 2017

David H Dockrell

series ordinal

2

1 reference

2 August 2017

publication date

1 February 2002

1 reference

International Journal of Antimicrobial Agents

2 August 2017

published in

1 reference

2 August 2017

volume

19

1 reference

2 August 2017

issue

2

1 reference

2 August 2017

page(s)

85-93

1 reference

American Academy of Pediatrics. Committee on Infectious Diseases. Technical report: prevention of pneumococcal infections, including the use of pneumococcal conjugate and polysaccharide vaccines and antibiotic prophylaxis

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900491-5

7 January 2021

Invasive pneumococcal disease in England and Wales: vaccination implications

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900491-5

7 January 2021

Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900491-5

7 January 2021

Epidemiology of invasive pneumococcal disease in southern California: implications for the design and conduct of a pneumococcal conjugate vaccine efficacy trial

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900491-5

7 January 2021

Epidemiology of invasive and other pneumococcal disease in children in England and Wales 1996-1998.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900491-5

7 January 2021

Geographical differences in invasive pneumococcal disease rates and serotype frequency in young children

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900491-5

7 January 2021

Invasive pneumococcal infection in South and West England.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900491-5

7 January 2021

Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995-1998: Opportunities for prevention in the conjugate vaccine era

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900491-5

7 January 2021

High incidence rates of invasive pneumococcal disease in the White Mountain Apache population

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900491-5

7 January 2021

The epidemiology of invasive pneumococcal disease in Alaska, 1986-1990--ethnic differences and opportunities for prevention.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900491-5

7 January 2021

Invasive pneumococcal disease in central Australia.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900491-5

7 January 2021

The epidemiology of pneumococcal infection in children in the developing world

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900491-5

7 January 2021

Invasive pneumococcal infection in Baltimore, Md: implications for immunization policy

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900491-5

7 January 2021

Cigarette smoking and invasive pneumococcal disease. Active Bacterial Core Surveillance Team

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900491-5

7 January 2021

Bacteraemic pneumococcal infections in Southern Sweden 1981-96: trends in incidence, mortality, age-distribution, serogroups and penicillin-resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900491-5

7 January 2021

An outbreak of multidrug-resistant pneumococcal pneumonia and bacteremia among unvaccinated nursing home residents.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900491-5

7 January 2021

An epidemic of pneumococcal disease in an overcrowded, inadequately ventilated jail

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900491-5

7 January 2021

Risk factors for invasive pneumococcal disease in children: a population-based case-control study in North America

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900491-5

7 January 2021

Molecular epidemiology of Streptococcus pneumoniae causing invasive disease in 5 countries.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900491-5

7 January 2021

Assessing costs and cost effectiveness of pneumococcal disease and vaccination within Kaiser Permanente

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900491-5

7 January 2021

Pneumococcal carriage in children in The Netherlands: a molecular epidemiological study

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900491-5

7 January 2021

Relationship between nasopharyngeal colonization and the development of otitis media in children. Tonawanda/Williamsville Pediatrics

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900491-5

7 January 2021

Risk factors for carriage of respiratory pathogens in the nasopharynx of healthy children

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900491-5

7 January 2021

Lobar pneumonia: an occupational disease in welders

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900491-5

7 January 2021

Prospective study of prognostic factors in community-acquired bacteremic pneumococcal disease in 5 countries

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900491-5

7 January 2021

High prevalence of penicillin-nonsusceptible Streptococcus pneumoniae at a community hospital in Oklahoma

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900491-5

7 January 2021

Invasive pneumococcal disease in a cohort of predominantly HIV-1 infected female sex-workers in Nairobi, Kenya

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900491-5

7 January 2021

Prevalence of human immunodeficiency virus infection, mortality rate, and serogroup distribution among patients with pneumococcal bacteremia at Denver General Hospital, 1984-1994.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900491-5

7 January 2021

Epidemiologic relation between HIV and invasive pneumococcal disease in San Francisco County, California

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900491-5

7 January 2021

Bacteremic pneumococcal pneumonia in HIV-seropositive and HIV-seronegative adults.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900491-5

7 January 2021

Increased risk of bacterial pneumonia in HIV-infected intravenous drug users without AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900491-5

7 January 2021

Streptococcus pneumoniae colonization, bacteremia, and immune response among persons with human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900491-5

7 January 2021

Colonization by Streptococcus penumoniae in human immunodeficiency virus-infected children

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900491-5

7 January 2021

Antimicrobial resistance of Streptococcus pneumoniae isolates in 1999 and 2000 in Madrid, Spain: a multicentre surveillance study

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900491-5

7 January 2021

Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in Asia and Europe, 1997-1998

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900491-5

7 January 2021

Penicillin resistance in laboratory isolates of Streptococcus pneumoniae, in Western Australia, 1990-1994.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900491-5

7 January 2021

Epidemiological features and prognosis of severe community-acquired pneumococcal pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900491-5

7 January 2021

Pneumonia acquired in the community through drug-resistant Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900491-5

7 January 2021

Clinical significance of pneumococcal bacteraemias in a general hospital: a prospective study 1989-1993.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900491-5

7 January 2021

Impact of penicillin susceptibility on medical outcomes for adult patients with bacteremic pneumococcal pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900491-5

7 January 2021

Adult bacteremic pneumococcal pneumonia in a community teaching hospital, 1992-1996. A detailed analysis of 108 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900491-5

7 January 2021

Early predictors of mortality in pneumococcal bacteraemia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900491-5

7 January 2021

Clinical and microbiological epidemiology of Streptococcus pneumoniae bacteraemia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900491-5

7 January 2021

Serotypes/groups distribution and antimicrobial resistance of invasive pneumococcal isolates: implications for vaccine strategies.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900491-5

7 January 2021

Pneumococcal bacteremia in adults in Soweto, South Africa, during the course of a decade

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900491-5

7 January 2021

Antimicrobial resistance of Streptococcus pneumoniae isolated in Taiwan: an island-wide surveillance study between 1996 and 1997.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900491-5

7 January 2021

Epidemiology of Streptococcus pneumoniae infection in Malaysia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900491-5

7 January 2021

Constancy of distribution of serogroups of invasive pneumococcal isolates among children: experience during 4 decades.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900491-5

7 January 2021

Clones of Streptococcus pneumoniae isolated from nasopharyngeal carriage and invasive disease in young children in central Tennessee

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900491-5

7 January 2021

The protective efficacy of polyvalent pneumococcal polysaccharide vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900491-5

7 January 2021

Efficacy of pneumococcal vaccine in high-risk patients. Results of a Veterans Administration Cooperative Study

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900491-5

7 January 2021

Randomised trial of 23-valent pneumococcal capsular polysaccharide vaccine in prevention of pneumonia in middle-aged and elderly people. Swedish Pneumococcal Vaccination Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900491-5

7 January 2021

Clinical efficacy of pneumococcal vaccine in the elderly: a randomized, single-blind population-based trial

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900491-5

7 January 2021

The clinical effectiveness of pneumococcal vaccination: a brief review

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900491-5

7 January 2021

Rethinking recommendations for use of pneumococcal vaccines in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900491-5

7 January 2021

Pneumococcal polysaccharide vaccine efficacy. An evaluation of current recommendations

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900491-5

7 January 2021

Preventing pneumococcal bacteremia in patients at risk. Results of a matched case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900491-5

7 January 2021

The health and economic benefits associated with pneumococcal vaccination of elderly persons with chronic lung disease

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900491-5

7 January 2021

Effects of a large-scale intervention with influenza and 23-valent pneumococcal vaccines in adults aged 65 years or older: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900491-5

7 January 2021

Responsiveness of human immunodeficiency virus type 1-infected Kenyan women with or without prior pneumococcal disease to pneumococcal vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900491-5

7 January 2021

Antibody class and subclass responses to pneumococcal polysaccharides following immunization of human immunodeficiency virus-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900491-5

7 January 2021

23-valent pneumococcal polysaccharide vaccine in HIV-1-infected Ugandan adults: double-blind, randomised and placebo controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900491-5

7 January 2021

Pneumococcal disease among human immunodeficiency virus-infected persons: incidence, risk factors, and impact of vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900491-5

7 January 2021

Pneumococcal vaccination: the response of patients with alcoholic liver cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900491-5

7 January 2021

Response to pneumococcal vaccine in renal allograft recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900491-5

7 January 2021

Effect of immunosuppression after cardiac transplantation in early childhood on antibody response to polysaccharide antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900491-5

7 January 2021

Antibody response to pneumococcal vaccine in children receiving bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900491-5

7 January 2021

Pneumococcal vaccine response in cirrhosis and liver transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900491-5

7 January 2021

Antibody responses to polysaccharide and polysaccharide-conjugate vaccines after treatment of Hodgkin disease

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900491-5

7 January 2021

Immunogenicity of vaccination against influenza, Streptococcus pneumoniae and Haemophilus influenzae type B in patients with multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900491-5

7 January 2021

Response to vaccination against different types of antigens in patients with chronic lymphocytic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900491-5

7 January 2021

Immunization of Immunosuppressed Patients with Pneumococcal Polysaccharide Vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900491-5

7 January 2021

A decade (1989-1998) of pediatric invasive pneumococcal disease in 2 populations residing in 1 geographic location: implications for vaccine choice

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900491-5

7 January 2021

Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900491-5

7 January 2021

Immunogenicity and tolerance of a 7-valent pneumococcal conjugate vaccine in nonresponders to the 23-valent pneumococcal vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900491-5

7 January 2021

The burden of pneumococcal disease: the role of conjugate vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900491-5

7 January 2021

Efficacy of pneumococcal vaccination in adults. A meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900491-5

7 January 2021

Guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900491-5

7 January 2021

Persistence of antibodies to pneumococcal capsular polysaccharide vaccine in the elderly.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900491-5

7 January 2021

Cost-effectiveness of pneumococcal vaccination of older people: a study in 5 western European countries

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900491-5

7 January 2021

10.1016/S0924-8579(01)00491-5

Identifiers

DOI

1 reference

2 August 2017

1 reference